STRIVE Post-Market Registry Study

Status Recruiting

Clinical Trial Summary

This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.

Clinical Trial Description

This post-market study is a single-arm, prospective, multi-center Registry. It is designed to assess 36-month safety and effectiveness of this FDA approved product in a post-approval setting, and to support the continued assessment of Spiration Valve System therapy for the treatment of severe emphysema in the United States. Subjects who are eligible and consent to be in this study, will be monitored for outcome data from baseline through 3 years post-first implant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04302272
Study type	Observational [Patient Registry]
Source	Olympus Corporation of the Americas
Contact	Lauri DeVore
Phone	(425) 373-6802
Email	lauri.devore@olympus.com
Status	Recruiting
Phase
Start date	October 9, 2021
Completion date	April 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05825261` - Exploring Novel Biomarkers for Emphysema Detection
Completed	`NCT02914340` - REACH SVS Control Patient Cross-Over Study	N/A
Completed	`NCT02999685` - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients	N/A
Completed	`NCT02238327` - Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT01615484` - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability	N/A
Withdrawn	`NCT01908933` - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema	Phase 3
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT01710449` - Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen	Phase 1
Completed	`NCT00475007` - Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema	N/A
Suspended	`NCT00523094` - Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure	N/A
Recruiting	`NCT00129350` - Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation	Phase 1
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Completed	`NCT00000621` - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)	Phase 2
Completed	`NCT00005292` - Alpha1-antitrypsin Deficiency Registry	N/A
Recruiting	`NCT04537182` - Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema	N/A
Active, not recruiting	`NCT02713347` - Advancing Symptom Alleviation With Palliative Treatment	N/A
Completed	`NCT04435327` - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed	`NCT03636347` - A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.	Phase 2
Terminated	`NCT02838108` - The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort